Core Viewpoint - Rosen Law Firm is reminding investors who purchased Avantor, Inc. common stock during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Avantor common stock between March 5, 2024, and October 28, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors can submit their information through the provided link or contact the law firm directly [3][6]. - The deadline to move the Court to serve as lead plaintiff is December 29, 2025, which is crucial for those wishing to represent other class members [3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own achievements in this area [4]. - The firm has successfully recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. Group 3: Case Allegations - The lawsuit alleges that Avantor's management misrepresented the company's competitive position and failed to disclose negative impacts from increased competition, leading to materially false and misleading statements about the company's business and prospects [5].

Core Viewpoint - A class action securities lawsuit has been filed against Avantor, Inc. alleging securities fraud that negatively impacted investors between March 5, 2024, and October 28, 2025 [1][2]. Group 1: Lawsuit Details - The complaint claims that Avantor's competitive positioning was misrepresented, indicating it was weaker than publicly stated [2]. - It is alleged that Avantor faced negative impacts from increased competition, which were not disclosed [2]. - The defendants' statements regarding the company's business operations and prospects are claimed to be materially false and misleading [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until December 29, 2025, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff to share in any potential recovery [3]. - Class members may be entitled to compensation without incurring out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive experience in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as a leading securities litigation firm in the U.S. [4].

Core Viewpoint - A class action securities lawsuit has been filed against Avantor, Inc. for alleged securities fraud affecting investors between March 5, 2024, and October 28, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Avantor's competitive positioning was misrepresented, indicating it was weaker than publicly stated [2]. - It is alleged that Avantor faced negative impacts from increased competition, which were not disclosed [2]. - The defendants' statements regarding the company's business operations and prospects are claimed to be materially false and misleading [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until December 29, 2025, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and there are no out-of-pocket costs for class members [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing significant compensation for shareholders and is recognized as a leading firm in securities litigation [4]. - The firm has over 20 years of experience and a team of more than 70 employees dedicated to serving clients [4].

Accessibility StatementSkip Navigation Research & Development Council of New Jersey honors Avantor for developing a biodegradable detergent solution that advances safe, sustainable biomanufacturing RADNOR, Pa., Nov. 25, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced the Company, in partnership with Amgen, received a 2025 Edison Patent Award from the ...

Core Viewpoint - Rosen Law Firm is encouraging investors of Avantor, Inc. to secure legal counsel before the December 29, 2025 deadline for a class action lawsuit related to the company's stock performance during the specified class period [2][3]. Group 1: Class Action Details - The class period for the Avantor, Inc. stock is defined as March 5, 2024, to October 28, 2025, inclusive [2]. - Investors who purchased Avantor common stock during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company, and has consistently ranked highly in terms of settlements achieved [5]. Group 3: Allegations Against Avantor - The lawsuit alleges that Avantor misrepresented its competitive positioning and failed to disclose negative impacts from increased competition, leading to materially false and misleading statements about its business and prospects [6].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Avantor, Inc. regarding a class action lawsuit due to alleged misleading statements and failure to disclose important information about the company's competitive positioning and operational challenges [1][3]. Group 1: Allegations - The complaint alleges that during the class period from March 5, 2024, to October 28, 2025, Avantor's competitive positioning was weaker than publicly represented [3]. - It is claimed that Avantor was negatively affected by increased competition, which was not disclosed by the defendants [3]. - As a result, the representations made by the defendants about the company's business, operations, and prospects were materially false and misleading [3]. Group 2: Class Action Details - Shareholders who purchased shares of AVTR during the specified class period are encouraged to contact the Gross Law Firm for possible lead plaintiff appointment [1][4]. - The deadline for shareholders to register for the class action and seek lead plaintiff status is December 29, 2025 [4]. - There is no cost or obligation for shareholders to participate in the case, and they will be enrolled in a portfolio monitoring software for status updates [4]. Group 3: Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [5]. - The firm aims to ensure that companies adhere to responsible business practices and engage in good corporate citizenship [5]. - The firm seeks recovery for investors who incurred losses due to false or misleading statements that led to artificial inflation of the company's stock [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Avantor, Inc. for alleged violations of federal securities laws, encouraging affected investors to participate in a class action lawsuit [2][5]. Group 1: Allegations Against Avantor - The complaint alleges that Avantor and its executives made false and misleading statements regarding the company's competitive positioning and the impact of increased competition [5]. - Specific claims include that Avantor's competitive position was weaker than represented, and that the company was negatively affected by heightened competition [5][6]. - During an earnings call on July 26, 2024, the then-CEO assured investors of Avantor's strong competitive position, which later proved to be misleading [6]. Group 2: Financial Performance and Stock Impact - On April 25, 2025, Avantor reported disappointing Q1 2025 results, cutting its guidance and announcing the CEO's resignation, leading to a stock price drop of over 16.5% [7]. - The company continued to report poor financial results, including a year-over-year decrease in net sales for Q2 2025, further reducing its 2025 guidance to a projected organic revenue growth of -2% to 0% [8]. - By October 29, 2025, Avantor reported a net loss of $712 million for Q3 2025, primarily due to a non-cash goodwill impairment charge of $785 million, attributed to competitive pressures [10]. - Following the Q3 report, Avantor's stock price fell by more than 23% [11].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Avantor, Inc. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The class period for the Avantor common stock purchase is from March 5, 2024, to October 28, 2025 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - The deadline to move the Court to serve as lead plaintiff is December 29, 2025 [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [3]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [3]. - In 2019, the firm secured over $438 million for investors [3]. Group 3: Case Allegations - The lawsuit alleges that Avantor's competitive positioning was misrepresented, indicating it was weaker than publicly stated [4]. - It claims that Avantor faced negative impacts from increased competition, which were not disclosed [4]. - The representations made by defendants regarding Avantor's business and prospects were materially false and misleading [4].

Core Insights - The CEO of Avantor, Emmanuel Ligner, demonstrated confidence in the company's stock by purchasing 87,500 shares, increasing his direct ownership to 283,424 shares, reflecting a bullish outlook on the stock's potential [1][9]. Transaction Summary - The transaction involved 87,500 shares traded at a value of $993,125, with a post-transaction ownership of 283,424 shares valued at approximately $3,083,653 based on the trade-date close price of $10.88 [2][6]. Company Overview - Avantor employs 13,500 individuals and reported a total revenue of $6.58 billion with a net income loss of $82.20 million over the trailing twelve months [4]. - The company's stock experienced a significant decline of 43.42% over the past year as of the transaction date [4]. Impact of the Purchase - The purchase increased Ligner's direct holdings by 44.66%, raising his ownership stake to 0.0416% of total shares outstanding [6]. - This transaction is noted as the largest reported trade for Ligner, both in terms of share count and percentage increase in direct holdings [6]. Company Profile - Avantor provides a wide range of high-purity materials, reagents, laboratory supplies, and specialty procurement services across various sectors, including biopharma, healthcare, and advanced technology [7][8]. - The company generates revenue primarily through consumables, customized materials, and laboratory equipment, along with value-added services [7]. Recent Performance and Outlook - Following a 52-week low of $10.83, Ligner's purchase suggests a positive outlook, coinciding with Avantor's initiation of a $500 million stock repurchase program [9]. - The company faced challenges in Q3, with a 5% year-over-year revenue decline to $1.62 billion and a significant goodwill impairment charge of $785 million, resulting in a net loss of $711.8 million [10].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Avantor, Inc. for allegedly misleading investors regarding the company's competitive positioning and financial performance during the specified class period [1][3]. Group 1: Allegations Against Avantor - The complaint alleges that Avantor and its executives violated federal securities laws by making false and misleading statements about the company's competitive position and the impact of increased competition [3]. - Defendants are accused of downplaying the effects of competition, with the CEO previously assuring investors of the company's strong competitive standing during earnings calls [4]. Group 2: Financial Performance and Stock Impact - Investors became aware of the negative impact of competition on Avantor's business when the company reported disappointing Q1 2025 results, leading to a stock price decline of over 16.5% [5][6]. - Following further disappointing financial results in Q2 2025, including a projected organic revenue growth of -2% to 0%, the stock price fell by more than 15% [5][6]. - In Q3 2025, Avantor reported a net loss of $712 million, primarily due to a non-cash goodwill impairment charge of $785 million, which was attributed to competitive pressures, resulting in a stock price drop of over 23% [7][8].